| Primary |
| Convulsion |
56.1% |
| Epilepsy |
16.0% |
| Grand Mal Convulsion |
6.8% |
| Hypertension |
3.8% |
| Pain |
2.7% |
| Convulsion Prophylaxis |
2.1% |
| Ill-defined Disorder |
2.1% |
| Depression |
1.1% |
| Anxiety |
1.0% |
| Cardiac Disorder |
0.9% |
| Drug Use For Unknown Indication |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Prophylaxis |
0.9% |
| Blood Cholesterol Increased |
0.8% |
| Partial Seizures |
0.7% |
| Petit Mal Epilepsy |
0.7% |
| Headache |
0.7% |
| Dementia Alzheimer's Type |
0.6% |
| Diabetes Mellitus |
0.6% |
| Hypothyroidism |
0.6% |
|
| Stevens-johnson Syndrome |
25.6% |
| Convulsion |
19.6% |
| Toxic Epidermal Necrolysis |
6.8% |
| Weight Decreased |
5.2% |
| Tremor |
4.3% |
| Somnolence |
3.6% |
| Drug Ineffective |
3.4% |
| Grand Mal Convulsion |
3.4% |
| Weight Increased |
3.3% |
| Vomiting |
3.2% |
| Toxicity To Various Agents |
2.7% |
| Drug Hypersensitivity |
2.6% |
| Rash |
2.6% |
| Vision Blurred |
2.3% |
| Malaise |
2.2% |
| Pharmaceutical Product Complaint |
2.0% |
| Drug Level Decreased |
1.8% |
| Visual Acuity Reduced |
1.8% |
| Dysphagia |
1.7% |
| Unevaluable Event |
1.7% |
|
| Secondary |
| Convulsion |
42.9% |
| Epilepsy |
11.8% |
| Product Used For Unknown Indication |
9.3% |
| Drug Use For Unknown Indication |
5.9% |
| Hypertension |
4.7% |
| Grand Mal Convulsion |
3.5% |
| Pain |
3.3% |
| Convulsion Prophylaxis |
2.0% |
| Anxiety |
2.0% |
| Depression |
1.9% |
| Cardiac Disorder |
1.7% |
| Diabetes Mellitus |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Urinary Tract Infection |
1.5% |
| Headache |
1.2% |
| Status Epilepticus |
1.2% |
| Agitation |
1.1% |
| Multiple Allergies |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Crohn's Disease |
0.9% |
|
| Stevens-johnson Syndrome |
45.8% |
| Convulsion |
8.7% |
| Toxic Epidermal Necrolysis |
7.4% |
| Weight Decreased |
4.1% |
| Weight Increased |
4.0% |
| Tremor |
3.4% |
| Drug Ineffective |
3.0% |
| Vision Blurred |
2.8% |
| Vomiting |
2.8% |
| Grand Mal Convulsion |
2.0% |
| Somnolence |
1.9% |
| Memory Impairment |
1.8% |
| Pain |
1.7% |
| Rash |
1.7% |
| Anticonvulsant Drug Level Decreased |
1.5% |
| Anticonvulsant Drug Level Increased |
1.5% |
| Drug Hypersensitivity |
1.5% |
| Fatigue |
1.5% |
| Myocardial Infarction |
1.5% |
| Thrombocytopenia |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.7% |
| Convulsion |
16.3% |
| Drug Use For Unknown Indication |
10.2% |
| Epilepsy |
6.3% |
| Pain |
6.1% |
| Depression |
4.1% |
| Hypertension |
3.9% |
| Multiple Sclerosis |
3.5% |
| Osteoporosis |
3.4% |
| Glioblastoma Multiforme |
3.3% |
| Anxiety |
3.0% |
| Nuclear Magnetic Resonance Imaging |
2.2% |
| Rheumatoid Arthritis |
2.1% |
| Asthma |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Blood Cholesterol Increased |
1.7% |
| Bipolar Disorder |
1.7% |
| Constipation |
1.6% |
| Smoking Cessation Therapy |
1.6% |
| Sleep Disorder |
1.5% |
|
| Convulsion |
15.6% |
| Vomiting |
10.5% |
| Weight Decreased |
7.1% |
| Drug Ineffective |
6.7% |
| Weight Increased |
6.3% |
| Somnolence |
4.9% |
| Type 2 Diabetes Mellitus |
4.8% |
| Death |
4.4% |
| Tremor |
4.4% |
| Pain |
4.1% |
| Urinary Tract Infection |
4.0% |
| Vision Blurred |
3.9% |
| Nausea |
3.8% |
| Pneumonia |
3.7% |
| Rash |
3.1% |
| Grand Mal Convulsion |
2.7% |
| Pruritus |
2.7% |
| Pyrexia |
2.5% |
| White Blood Cell Count Decreased |
2.5% |
| Pancreatitis |
2.3% |
|
| Interacting |
| Convulsion |
32.6% |
| Product Used For Unknown Indication |
14.8% |
| Epilepsy |
9.2% |
| Grand Mal Convulsion |
7.5% |
| Lyme Disease |
4.3% |
| Hypertension |
4.1% |
| Pain |
3.9% |
| Convulsion Prophylaxis |
3.4% |
| Hypothyroidism |
2.6% |
| Depression |
2.1% |
| Sinusitis |
2.1% |
| Hypersensitivity |
1.7% |
| Thyroidectomy |
1.7% |
| Anxiety |
1.5% |
| Blood Pressure Abnormal |
1.5% |
| Cervix Carcinoma |
1.5% |
| Post-traumatic Epilepsy |
1.5% |
| Back Disorder |
1.3% |
| Drug Use For Unknown Indication |
1.3% |
| Fungal Infection |
1.3% |
|
| Drug Interaction |
23.7% |
| Weight Increased |
13.2% |
| Weight Decreased |
9.6% |
| Sinusitis |
7.0% |
| Tongue Disorder |
6.1% |
| Feeling Abnormal |
4.4% |
| Grand Mal Convulsion |
3.5% |
| Hepatic Enzyme Increased |
3.5% |
| Palpitations |
3.5% |
| Speech Disorder |
3.5% |
| Dizziness |
2.6% |
| Drug Level Decreased |
2.6% |
| Headache |
2.6% |
| Rash Macular |
2.6% |
| Urinary Tract Infection |
2.6% |
| Convulsion |
1.8% |
| Cystitis |
1.8% |
| Drug Level Increased |
1.8% |
| Nervousness |
1.8% |
| Partial Seizures |
1.8% |
|